0 results for 'Nixon Peabody'
At risk drug launches, in which a generic manufacturer launches its version of a brand-name drug without a finding that the brand manufacturer's patent is invalid or not infringed, amount to a high-stakes game of chicken by the generic. They're rarely attempted--and the fate of Dr. Reddy's version of Allegra-D shows why.
Del. Supreme Court Upholds Libel Verdict Against Newspaper
The Delaware Supreme dealt a double blow to the The News Journal of Wilmington, Del., in a libel case. The court affirmed a jury verdict finding that a doctor was wronged by a newspaper story insinuating she recommended surgery for financial gain. The court also threw out a $2.8-million damage award for a new reckoning that would take into account the wealth of the Gannett Co., which owns the newspaper.A federal district court jury in Virginia's Eastern District sided with a group of wireless carriers and a data card maker in a spat with patent holder Acacia Technologies.
State AI Legislation Is on the Move in 2024
Brought to you by LexisNexis®
Download Now
2024 ESI Risk Management & Litigation Readiness Report
Brought to you by Pagefreezer
Download Now
Creating a Culture of Compliance
Brought to you by Ironclad
Download Now
A Buyer's Guide to Law Firm Software
Brought to you by PracticePanther
Download Now